Improvement of Antimicrobial Drug Administration Using an Anti-biogram and Critical Path-Reference-Cited by-同舟云学术

Improvement of Antimicrobial Drug Administration Using an Anti-biogram and Critical Path

Published:2019-01-25 Issue:1 Volume:34 Page:28-39
ISSN:1882-532X
Container-title:Japanese Journal of Infection Prevention and Control
language:en
Short-container-title:Nihon Kankyou Kansen Gakkaishi

Author:

MATSUKI Yoshihiko¹²,ISHIGE Koji¹²,ISHIDA Masanari²,ATOJI Erina¹³,KAZAMA Takemi¹⁴,TANIHIRA Tetsuya⁵,ARAKI Kazunori¹⁶,WATANABE Tamaki⁷,WATANABE Shigekazu⁷

Affiliation:

1. Infection Control Committee, Kashiwa Kousei General Hospital, Ageo Medical Group

2. Department of Pharmacy, Kashiwa Kousei General Hospital, Ageo Medical Group

3. Department of Nursing, Kashiwa Kousei General Hospital, Ageo Medical Group

4. Department of Clinical Laboratory, Kashiwa Kousei General Hospital, Ageo Medical Group

5. Department of Internal Medicine, Kashiwa Kousei General Hospital, Ageo Medical Group

6. Department of Pediatrics, Kashiwa Kousei General Hospital, Ageo Medical Group

7. Practical Pharmacy of Pharmaceutical Sciences, Teikyo University

Publisher

Japanese Society of Environmental Infections

Subject

Epidemiology

Link

https://www.jstage.jst.go.jp/article/jsei/34/1/34_28/_pdf

Reference5 articles.

1. 1) Giske C G, Monnet D L, Cars O, Carmeli Y: ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008; 52: 813-21.

2. 6) Gilbert DN, Chambers HF, Eliopoulos GM, Saag MS, Pavia AT: The Sanford guide to antimicrobial therapy 2016: 46th edition, Antimicrobial Therapy, Inc, Hyde Park, 2016. p. 127, p. 215-22.

3. 7) WHO collaborating centre for drug statistics methodology: ATC/DDD index 2018: http://www.whocc.no/atcddd/

4. 8) Zagorski BM, Trick WE, Schwartz DN, Wisniewski MF, Hershow RC, Fridkin SK, et al.: The eŠect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis 2002; 35: 1491-7.

5. 10) Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing-22th informational supplement. Approved standard, CLSI document M100-S22, CLSI, 2012.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Adoption of Metronidazole Injection Formulation on the Use of Meropenem and Tazobactam/piperacillin;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-03-10